These results demonstrate that LNP-Kd/Statin achieves synthetic lethality by dual targeting of ISG15 and HMGCR, effectively eradicating CSCs and bulk tumor cells while preserving systemic tolerability. Here, EEF1A2 is linked to neoplasm.